|
|
- 2018
A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancersDOI: 10.1186/s40170-018-0181-8 Keywords: Precision medicine, Warburg effect, Liver cancer, Cancer, Glycolysis, Hexokinase 2, Diphenyleneiodonium, Perhexiline, Fatty acid oxidation, Oxidative phosphorylation, Mitochondria complex-I, Synthetic lethality Abstract: The online version of this article (10.1186/s40170-018-0181-8) contains supplementary material, which is available to authorized users
|
